Kangmei Pharmaceutical Co., Ltd. (SHA:600518)
China
· Delayed Price · Currency is CNY 2.130
-0.060 (-2.74%)
Feb 28, 2025, 3:00 PM CST
Kangmei Pharmaceutical Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Feb '25 Feb 27, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 29,530 | 25,787 | 30,501 | 42,839 | 13,330 | 18,553 | Upgrade
|
| Market Cap Growth | 10.75% | -15.45% | -28.80% | 221.38% | -28.15% | -59.50% | Upgrade
|
| Enterprise Value | 29,006 | 24,904 | 28,797 | 76,028 | 47,878 | 54,483 | Upgrade
|
| Last Close Price | 2.13 | 1.86 | 2.20 | 3.09 | 2.68 | 3.73 | Upgrade
|
| PE Ratio | 115.56 | 251.53 | - | 5.41 | - | - | Upgrade
|
| Forward PE | - | 2.56 | 2.56 | 2.56 | 2.56 | 2.56 | Upgrade
|
| PS Ratio | 5.66 | 5.29 | 7.30 | 10.32 | 2.46 | 1.62 | Upgrade
|
| PB Ratio | 4.19 | 3.64 | 4.37 | 4.30 | -1.28 | 0.90 | Upgrade
|
| P/TBV Ratio | 4.41 | 4.00 | 4.83 | 4.64 | - | 1.20 | Upgrade
|
| P/FCF Ratio | - | - | - | 1006.12 | 18.27 | 7.70 | Upgrade
|
| P/OCF Ratio | - | - | - | 199.99 | 12.92 | 6.44 | Upgrade
|
| PEG Ratio | 0.53 | 0.53 | 0.53 | 0.53 | 0.53 | 0.53 | Upgrade
|
| EV/Sales Ratio | 5.56 | 5.11 | 6.89 | 18.31 | 8.85 | 4.76 | Upgrade
|
| EV/EBITDA Ratio | 48.35 | 50.72 | - | - | - | - | Upgrade
|
| EV/EBIT Ratio | 104.48 | 121.27 | - | - | - | - | Upgrade
|
| EV/FCF Ratio | -57.70 | - | - | 1785.59 | 65.62 | 22.62 | Upgrade
|
| Debt / Equity Ratio | 0.03 | 0.04 | 0.04 | 0.02 | -2.09 | 1.59 | Upgrade
|
| Debt / EBITDA Ratio | 0.36 | 0.47 | - | - | - | - | Upgrade
|
| Debt / FCF Ratio | - | - | - | 4.82 | 29.78 | 13.67 | Upgrade
|
| Asset Turnover | 0.36 | 0.33 | 0.27 | 0.17 | 0.11 | 0.17 | Upgrade
|
| Inventory Turnover | 1.60 | 1.54 | 1.26 | 0.91 | 1.57 | 0.32 | Upgrade
|
| Quick Ratio | 0.77 | 0.86 | 0.82 | 1.00 | 0.54 | 0.54 | Upgrade
|
| Current Ratio | 1.43 | 1.46 | 1.36 | 1.67 | 0.80 | 1.69 | Upgrade
|
| Return on Equity (ROE) | 3.71% | 1.47% | -31.78% | - | -607.26% | -19.91% | Upgrade
|
| Return on Assets (ROA) | 1.21% | 0.87% | -4.16% | -7.71% | -34.20% | -1.55% | Upgrade
|
| Return on Capital (ROIC) | 2.41% | 1.76% | -7.46% | -17.72% | -51.60% | -1.84% | Upgrade
|
| Return on Capital Employed (ROCE) | 2.99% | 2.14% | - | - | - | - | Upgrade
|
| Earnings Yield | 0.87% | 0.40% | -8.81% | 18.48% | -233.20% | -25.12% | Upgrade
|
| FCF Yield | -1.70% | -1.62% | -2.62% | 0.10% | 5.47% | 12.98% | Upgrade
|
| Payout Ratio | 0.00% | - | - | 0.17% | - | - | Upgrade
|
| Buyback Yield / Dilution | -0.03% | 27.54% | -1.85% | -0.55% | -179.83% | 20.41% | Upgrade
|
| Total Shareholder Return | -0.03% | 27.54% | -1.85% | -0.55% | -179.83% | 20.41% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.